RE
GILD icon

RBC Europe’s Gilead Sciences GILD Stock Holding History

RBC Europe’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$219K Hold
3,547
– – 0.01% 197
2022
Q1 		$211K Sell
3,547
-218
-6% -$13.9K 0.01% 216
2021
Q4 		$273K Buy
3,765
+1,187
+46% +$81.8K 0.01% 201
2021
Q3 		$180K Sell
2,578
-60
-2% -$4.21K 0.01% 317
2021
Q2 		$182K Sell
2,638
-40
-1% -$2.67K 0.01% 328
2021
Q1 		$173K Sell
2,678
-2,375
-47% -$153K 0.01% 312
2020
Q4 		$294K Sell
5,053
-80
-2% -$4.83K 0.02% 230
2020
Q3 		$324K Sell
5,133
-594
-10% -$41.2K 0.02% 205
2020
Q2 		$441K Buy
5,727
+140
+3% +$10.7K 0.03% 173
2020
Q1 		$418K Buy
5,587
+1,280
+30% +$88.4K 0.04% 147
2019
Q4 		$280K Sell
4,307
-272
-6% -$17.7K 0.02% 204
2019
Q3 		$290K Buy
4,579
+76
+2% +$4.97K 0.03% 204
2019
Q2 		$304K Sell
4,503
-375
-8% -$24.7K 0.03% 208
2019
Q1 		$317K Hold
4,878
– – 0.04% 195
2018
Q4 		$305K Hold
4,878
– – 0.04% 182
2018
Q3 		$377K Sell
4,878
-6,766
-58% -$511K 0.04% 185
2018
Q2 		$825K Sell
11,644
-565
-5% -$39.9K 0.1% 127
2018
Q1 		$920K Sell
12,209
-200
-2% -$15.9K 0.11% 114
2017
Q4 		$889K Hold
12,409
– – 0.11% 115
2017
Q3 		$1.01M Buy
+12,409
New +$949K 0.13% 104

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBC Europe's GILD Position: Q2 2022 in Review

RBC Europe held its Gilead Sciences (GILD) position steady in Q2 2022 at 3,547 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #197.

RBC Europe first reported a position in GILD in Q3 2017 and has held it in 20 quarters since. The position peaked at $1.01M in Q3 2017. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • RBC Europe held 3,547 shares of Gilead Sciences worth $219K as of Q2 2022.
  • RBC Europe left its Gilead Sciences share count unchanged in Q2 2022.
  • Gilead Sciences made up 0.01% of RBC Europe's portfolio in Q2 2022, its #197 holding.
  • RBC Europe first reported a position in Gilead Sciences in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Gilead Sciences position peaked at $1.01M in Q3 2017.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.